PRESCRIPTION TRANSPARENCY (2SHB 1541)
1/16/18 Priority bill, 2SHB 1541, addressing prescription drug cost transparency, has been moved to the full House for a final vote.
1/3/18 Requires drug manufacturers to report prescription drug pricing data to the Office of Financial Management (the state budget office), allowing policy-makers better tools to manage one of the largest cost-drivers of health care. Our state spends a tremendous amount of money on health care, and we can’t do anything to manage those costs until there is more transparency in pricing. In 2017, 2SHB 1541 passed the House and had a Senate hearing. Senate companion SB 5586.